Global Electrocardiographs Market

Focus on Product Type, End User, Region, COVID-19 Impact, Competitive Landscape, and 22 Countries Data - Analysis and Forecast, 2021-2031

Published Year: 2021
SKU: BHR1076SA

5250

Online Access for 1-3 Users. Permission to Print.


In case you require a hard copy, there will be an additional charge of $500. Please email us at [email protected] with your request.

A quick peek into the report

Table of Contents

Download this TOC  

Request a Sample

1 Scope of Research Study

1.1    Inclusion and Exclusion Criteria
1.2    Key Questions Answered in the Report

2 Research Methodology

2.1    Data Collection and Analysis
2.2    Data Sources
         2.2.1    Primary Data Sources
         2.2.2    Secondary Data Sources
2.3    Data Sources and Categorization
2.4    Data Triangulation
2.5    Estimation and Forecasting Methodology
2.6    Forecast Period Selection Criteria

3 Industry Outlook

3.1    Regulatory Scenario
         3.1.1    North America
                     3.1.1.1    U.S.
                     3.1.1.2    Canada
         3.1.2    European Union
         3.1.3    Asia-Pacific
                     3.1.3.1    China
                     3.1.3.2    Japan
         3.1.4    Latin America
                     3.1.4.1    Brazil
                     3.1.4.2    Mexico
3.2    Impact of COVID-19 Pandemic on the Market
3.3    Awaited Technological Advancements
         3.3.1    Remote ECG Monitoring Systems
         3.3.2    Wearable ECG Technologies
         3.3.3    Artificial Intelligence-Enabled Electrocardiographs
3.4    Patent Landscape
3.5    Value Chain Analysis
3.6    Architecture of Electrocardiographs System
3.7    Epidemiology Assessment
         3.7.1    Cardiovascular Disorders
         3.7.2    Atrial Fibrillation

4 Competitive Assessment

4.1    Market Share Analysis
         4.1.1    Global Electrocardiographs Market (by Company)
         4.1.2    Global Conventional Devices Market (by Company)
         4.1.3    Global Implantable Loop Recorders Market (by Company)
         4.1.4    Global Mobile Cardiac Telemetry Market (by Company)
         4.1.5    Global Holter Monitors Market (by Company)
4.2    Product Benchmarking
4.3    Market Attractiveness Analysis
         4.3.1    Product Type
         4.3.2    End User
         4.3.3    Region
4.4    Key Developments and Strategies (Deal Tracking)
         4.4.1    Collaborative Activities
         4.4.2    Regulatory Activities
         4.4.3    Merger and Acquisition Activities
         4.4.4    New Product Offerings

5 Market Dynamics

5.1    Impact Analysis
5.2    Market Drivers
         5.2.1    Increasing Prevalence of Cardiovascular Diseases (CVDs) and other Heart-Related Diseases
         5.2.2    Growing Demands for Point-of-Care Diagnostic Systems
         5.2.3    Rising End-User Preference for Non-Invasive Diagnostic Technologies over Invasive Technologies
5.3    Market Restraints
         5.3.1    Longer Turnaround Time (TAT)
         5.3.2    Incomplete and False Diagnosis
5.4    Market Trends
         5.4.1    Rise in Demand for Holter Monitors
         5.4.2    Development of Insertable Cardiac Monitors
5.5    Market Opportunities
         5.5.1    Growing Market Preference for Multimodal Diagnostic Imaging Systems
         5.5.2    Implementation of ECG in Hybrid Operating Rooms

6 Global Electrocardiographs Market

6.1    Global Market Outlook
6.2    Key Findings
6.3    Assumptions and Limitations

7 Global Electrocardiographs Market (by Product Type)

7.1    Overview
7.2    Market Size and Forecast
         7.2.1    Conventional Devices
                      7.2.1.1    Resting ECG Devices
                      7.2.1.2    Stress ECG Devices
          7.2.2    Emerging Devices
                      7.2.2.1    Implantable Loop Recorders
                      7.2.2.2    Mobile Cardiac Telemetry
                                     7.2.2.2.1.1    Lead-Based Mobile Cardiac Telemetry
                                     7.2.2.2.2    Patch-Based Mobile Cardiac Telemetry
                      7.2.2.3    Holter Monitors
                      7.2.2.4    Cardiac Event Monitors

8 Global Electrocardiographs Market (by End User)

8.1    Overview
         8.1.1    Market Size and Forecast
                     8.1.1.1    Hospitals and Clinics
                     8.1.1.2    Home Care Settings and Ambulatory Surgical Centers
                     8.1.1.3    Others

9 Global Electrocardiographs Market (by Region)

9.1    Overview
9.2    North America
         9.2.1    Key Findings
         9.2.2    Market Size and Forecast
                     9.2.2.1    Product Type
                     9.2.2.2    End User
                     9.2.2.3    Country
                                    9.2.2.3.1    U.S.
                                    9.2.2.3.2    Canada
9.3    Europe
         9.3.1    Key Findings
         9.3.2    Market Size and Forecast
                     9.3.2.1    Product Type
                     9.3.2.2    End User
                     9.3.2.3    Country
                                    9.3.2.3.1    Germany
                                    9.3.2.3.2    U.K.
                                    9.3.2.3.3    France
                                    9.3.2.3.4    Italy
                                    9.3.2.3.5    Spain
                                    9.3.2.3.6    Russia
                                    9.3.2.3.7    Nordic Countries
                                    9.3.2.3.8    Benelux Countries
                                    9.3.2.3.9    Rest-of-Europe
9.4    Asia-Pacific
         9.4.1    Key Findings
         9.4.2    Market Size and Forecast
                     9.4.2.1    Product Type
                     9.4.2.2    End User
                     9.4.2.3    Country
                                    9.4.2.3.1    China
                                    9.4.2.3.2    Japan
                                    9.4.2.3.3    South Korea
                                    9.4.2.3.4    India
                                    9.4.2.3.5    Australia and New Zealand
                                    9.4.2.3.6    Rest-of-Asia-Pacific
9.5    Latin America
         9.5.1    Key Findings
         9.5.2    Market Size and Forecast
                     9.5.2.1    Product Type
                     9.5.2.2    End User
                     9.5.2.3    Country
                                    9.5.2.3.1    Brazil
                                    9.5.2.3.2    Mexico
                                    9.5.2.3.3    Argentina
                                    9.5.2.3.4    Colombia
                                    9.5.2.3.5    Rest-of-Latin America
9.6    Middle East and Africa
         9.6.1    Key Findings
         9.6.2    Market Size and Forecast
                     9.6.2.1    Product Type
                     9.6.2.2    End User
                     9.6.2.3    Country
                                    9.6.2.3.1    K.S.A
                                    9.6.2.3.2    South Africa
                                    9.6.2.3.3    U.A.E
                                    9.6.2.3.4    Rest-of-Middle East and Africa

10 Company Profiles

10.1    Overview
10.2    Abbott Laboratories
           10.2.1    Company Outlook
           10.2.2    Company Description
           10.2.3    Financials
           10.2.4    SWOT Analysis
10.3    Biotricity, Inc.
           10.3.1    Company Outlook
           10.3.2    Company Description
           10.3.3    Financials
           10.3.4    SWOT Analysis
10.4    BIOTRONIK SE & Co. KG
           10.4.1    Company Overview
           10.4.2    Company Description
           10.4.3    SWOT Analysis
10.5    Boston Scientific Corporation
           10.5.1    Company Outlook
           10.5.2    Company Description
           10.5.3    Financials
           10.5.4    SWOT Analysis
10.6    CardioComm Solutions, Inc.
           10.6.1    Company Outlook
           10.6.2    Company Description
           10.6.3    Financials
           10.6.4    SWOT Analysis
10.7    Cardioline SpA
           10.7.1    Company Overview
           10.7.2    Company Description
           10.7.3    SWOT Analysis
10.8    Fukuda Denshi Co., Ltd.
           10.8.1    Company Outlook
           10.8.2    Company Description
           10.8.3    Financials
           10.8.4    SWOT Analysis
10.9    General Electric Company
           10.9.1    Company Outlook
           10.9.2    Company Description
           10.9.3    Financials
           10.9.4    SWOT Analysis
10.10    Hill-Rom Holdings, Inc.
             10.10.1    Company Outlook
             10.10.2    Company Description
             10.10.3    Financials
             10.10.4    SWOT Analysis
10.11    iRhythm Technologies, Inc.
             10.11.1    Company Outlook
             10.11.2    Company Description
             10.11.3    Financials
             10.11.4    SWOT Analysis
10.12    Koninklijke Philips N.V.
             10.12.1    Company Outlook
             10.12.2    Company Description
             10.12.3    Financials
             10.12.4    SWOT Analysis
10.13    Medtronic plc
             10.13.1    Company Outlook
             10.13.2    Company Description
             10.13.3    Financials
             10.13.4    SWOT Analysis
10.14    Nihon Kohden Corporation
             10.14.1    Company Outlook
             10.14.2    Company Description
             10.14.3    Financials
             10.14.4    SWOT Analysis
10.15    OSI Systems, Inc.
             10.15.1    Company Outlook
             10.15.2    Company Description
             10.15.3    Financials
             10.15.4    SWOT Analysis
10.16    Zoll Medical Corporation (Asahi Kasei Corporation)
             10.16.1    Company Outlook
             10.16.2    Company Description
             10.16.3    Financials
             10.16.4    SWOT Analysis

List of Tables

Table 3.1:    Medical Device Classification and Pre-Marketing Procedures in Japan
Table 3.2:    Patent Landscape (by Country), January 2017-July 2021
Table 4.1:    Product Benchmarking Analysis of Key Players
Table 5.1:    Impact Analysis: Market Drivers
Table 5.2:    Impact Analysis: Market Restraints
Table 9.1:    Prevalence of CVDs in North America Region (2000, 2010, 2018, and 2019)
Table 9.2:    North America Electrocardiographs Market (by Product Type), $Million, 2020-2031
Table 9.3:    Prevalence of CVDs in Europe Region (2000, 2010, 2018, and 2019)
Table 9.4:    Europe Electrocardiographs Market (by Product Type), $Million, 2020-2031
Table 9.5:    Prevalence of CVDs in Asia-Pacific Region (2000, 2010, 2018, and 2019)
Table 9.6:    Asia-Pacific Electrocardiographs Market (by Product Type), $Million, 2020-2031
Table 9.7:    Prevalence of CVDs in Latin America Region (2000, 2010, 2018, and 2019)
Table 9.8:    Latin America Electrocardiographs Market (by Product Type), $Million, 2020-2031
Table 9.9:    Prevalence of CVDs in Middle East and Africa Region (2000, 2010, 2018, and 2019)
Table 9.10:    Middle East and Africa Electrocardiographs Market (by Product Type), $Million, 2020-2031
Table 10.1:    Abbott Laboratories: R&D Investments, $Million, 2018-2020
Table 10.2:    Biotricity, Inc.: R&D Investments, $Million, 2018-2020
Table 10.3:    Boston Scientific Corporation: R&D Investments, $Million, 2018-2020
Table 10.4:    CardioComm Solutions, Inc.: R&D Investments, $Million, 2018-2020
Table 10.5:    General Electric Company: R&D Investments, $Million, 2018-2020
Table 10.6:    Hill-Rom Holdings, Inc.: R&D Investments, $Million, 2018-2020
Table 10.7:    iRhythm Technologies, Inc.: R&D Investments, $Million, 2018-2020
Table 10.8:    Koninklijke Philips N.V.: R&D Investments, $Million, 2018-2020
Table 10.9:    Medtronic plc: R&D Investments, $Million, 2019-2021
Table 10.10:    Nihon Kohden Corporation: R&D Investments, $Million, 2019-2021
Table 10.11:    OSI Systems, Inc.: R&D Investments, $Million, 2018-2020

List of Figures

Figure 1:    Global Electrocardiographs Market, $Million, 2020, 2024, 2027, and 2031
Figure 2:    Dominating Segments of the Global Electrocardiographs Market, $Million, 2020 and 2031
Figure 3:    Global Electrocardiographs Market (by Product Type), $Million, 2020, 2027,  and 2031
Figure 4:    Global Electrocardiographs Market (by End User), 2020, 2027, and 2031
Figure 5:    Global Electrocardiographs Market (by Region), $Million, 2020 and 2031
Figure 6:    Growth Propelling and Inhibiting Factors
Figure 7:    Key Developments and Strategies (by Category), January 2017-July 2021
Figure 1.1:    Global Electrocardiographs Market Segmentation
Figure 1.2:    Global Electrocardiographs Market, Regional Segmentation
Figure 2.1:    Global Electrocardiographs Market: Research Methodology
Figure 2.2:    Primary Research
Figure 2.3:    Secondary Research
Figure 2.4:    Data Triangulation
Figure 3.1:    Regulatory Process for Medical Devices in the U.S.
Figure 3.2:    Regulatory Process for Medical Devices in Canada
Figure 3.3:    MDR Transitional Provisions (EU)
Figure 3.4:    Regulatory Pathway for Medical Devices in China
Figure 3.5:    Postulated Cardiovascular Involvement in COVID-19 Pandemic
Figure 3.6:    Value Chain Analysis: Key Entities
Figure 3.7:    Architecture Overview
Figure 3.8:    Global Prevalence (Cardiovascular Disorders), $Million, 1990-2019
Figure 3.9:    Global Prevalence (Atrial Fibrillation), $Million, 1990-2019
Figure 4.1:    Global Electrocardiographs Market Share Analysis (by Company), 2020
Figure 4.2:    Global Conventional Devices Market Share Analysis (by Company), 2020
Figure 4.3:    Global Implantable Loop Recorders Market Share Analysis (by Company), 2020
Figure 4.4:    Global Mobile Cardiac Telemetry Market Share Analysis (by Company), 2020
Figure 4.5:    Global Holter Monitors Market Share Analysis (by Company), 2020
Figure 4.6:    Market Attractiveness Analysis (Product Type), 2020-2031
Figure 4.7:    Market Attractiveness Analysis (End User), 2020-2031
Figure 4.8:    Market Attractiveness Analysis (Region), 2020-2031
Figure 4.9:    Key Developments and Strategies (by Category), January 2017-July 2021
Figure 4.10:    Key Developments and Strategies (Collaborative Activities), January 2017-July 2021
Figure 4.11:    Key Developments and Strategies (Regulatory Activities), January 2017- July 2021
Figure 4.12:    Key Developments and Strategies (Merger and Acquisition Activities), January 2017-July 2021
Figure 4.13:    Key Developments and Strategies (New Product Offerings), January 2017-July 2021
Figure 5.1:    Market Dynamics
Figure 5.2:    Risk Assessment of Non-Invasive Testing
Figure 6.1:    Global Electrocardiographs Market, $Million, 2020-2031
Figure 7.1:    Global Electrocardiographs Market Segmentation (by Product Type)
Figure 7.2:    Opportunity Assessment (by Product Type), $Million, 2020, 2026, and 2031
Figure 7.3:    Global Electrocardiographs Market (Resting ECG Devices), $Million, 2020-2031
Figure 7.4:    Modifications of Stress Electrocardiographs
Figure 7.5:    Global Electrocardiographs Market (Stress ECG Devices), $Million, 2020-2031
Figure 7.6:    Global Electrocardiographs Market (Implantable Loop Recorders), $Million, 2020-2031
Figure 7.7:    Mobile Cardiac Telemetry (MCT) Workflow
Figure 7.8:    Global Electrocardiographs Market (Mobile Cardiac Telemetry), $Million,  2020-2031
Figure 7.9:    Global Electrocardiographs Market (Lead-Based Mobile Cardiac Telemetry), $Million, 2020-2031
Figure 7.10:    Global Electrocardiographs Market (Patch-Based Mobile Cardiac Telemetry), $Million, 2020-2031
Figure 7.11:    Holter Monitors Workflow
Figure 7.12:    Global Electrocardiographs Market (Holter Monitors), $Million, 2020-2031
Figure 7.13:    Types of Cardiac Event Monitors
Figure 7.14:    Global Electrocardiographs Market (Cardiac Event Monitors), $Million,  2020-2031
Figure 8.1:    Opportunity Assessment (by End-User), $Million, 2020, 2026, and 2031
Figure 8.2:    Global Electrocardiographs Market (Hospitals and Clinics), $Million, 2020-2031
Figure 8.3:    Global Electrocardiographs Market (Home Care Settings and Ambulatory Surgical Centers), $Million, 2020-2031
Figure 8.4:    Global Electrocardiographs Market (Others), $Million, 2020-2031
Figure 9.1:    Global Electrocardiographs Market Scenario (by Region), 2020 and 2031
Figure 9.2:    Opportunity Assessment (by Region), $Million, 2020, 2026, and 2031
Figure 9.3:    North America Electrocardiographs Market, $Million, 2020-2031
Figure 9.4:    North America Electrocardiographs Market (by Product Type), $Million,  2020-2031
Figure 9.5:    North America Electrocardiographs Market (by End User), $Million, 2020-2031
Figure 9.6:    U.S. Electrocardiographs Market, $Million, 2020-2031
Figure 9.7:    Canada Electrocardiographs Market, $Million, 2020-2031
Figure 9.8:    Europe Electrocardiographs Market, $Million, 2020-2031
Figure 9.9:    Europe Electrocardiographs Market (by Product Type), $Million, 2020-2031
Figure 9.10:    Europe Electrocardiographs Market (by End User), $Million, 2020-2031
Figure 9.11:    Germany Electrocardiographs Market, $Million, 2020-2031
Figure 9.12:    U.K. Electrocardiographs Market, $Million, 2020-2031
Figure 9.13:    France Electrocardiographs Market, $Million, 2020-2031
Figure 9.14:    Italy Electrocardiographs Market, $Million, 2020-2031
Figure 9.15:    Spain Electrocardiographs Market, $Million, 2020-2031
Figure 9.16:    Russia Electrocardiographs Market, $Million, 2020-2031
Figure 9.17:    Nordic Countries Electrocardiographs Market, $Million, 2020-2031
Figure 9.18:    Benelux Countries Electrocardiographs Market, $Million, 2020-2031
Figure 9.19:    Rest-of-Europe Electrocardiographs Market, $Million, 2020-2031
Figure 9.20:    Asia-Pacific Electrocardiographs Market, $Million, 2020-2031
Figure 9.21:    Asia-Pacific Electrocardiographs Market (by Product Type), $Million, 2020-2031
Figure 9.22:    Asia-Pacific Electrocardiographs Market (by End User), $Million, 2020-2031
Figure 9.23:    China Electrocardiographs Market, $Million, 2020-2031
Figure 9.24:    Japan Electrocardiographs Market, $Million, 2020-2031
Figure 9.25:    South Korea Electrocardiographs Market, $Million, 2020-2031
Figure 9.26:    India Electrocardiographs Market, $Million, 2020-2031
Figure 9.27:    Australia and New Zealand Electrocardiographs Market, $Million, 2020-2031
Figure 9.28:    Rest-of-Asia-Pacific Electrocardiographs Market, $Million, 2020-2031
Figure 9.29:    Latin America Electrocardiographs Market, $Million, 2020-2031
Figure 9.30:    Latin America Electrocardiographs Market (by Product Type), $Million, 2020-2031
Figure 9.31:    Latin America Electrocardiographs Market (by End User), $Million, 2020-2031
Figure 9.32:    Brazil Electrocardiographs Market, $Million, 2020-2031
Figure 9.33:    Mexico Electrocardiographs Market, $Million, 2020-2031
Figure 9.34:    Argentina Electrocardiographs Market, $Million, 2020-2031
Figure 9.35:    Colombia Electrocardiographs Market, $Million, 2020-2031
Figure 9.36:    Rest-of-Latin America Electrocardiographs Market, $Million, 2020-2031
Figure 9.37:    Middle East and Africa Electrocardiographs Market, $Million, 2020-2031
Figure 9.38:    Middle East and Africa Electrocardiographs Market (by Product Type), $Million, 2020-2031
Figure 9.39:    Middle East and Africa Electrocardiographs Market (by End User), $Million, 2020-2031
Figure 9.40:    K.S.A Electrocardiographs Market, $Million, 2020-2031
Figure 9.41:    South Africa Electrocardiographs Market, $Million, 2020-2031
Figure 9.42:    U.A.E Electrocardiographs Market, $Million, 2020-2031
Figure 9.43:    Rest-of-Middle East and Africa Electrocardiographs Market, $Million, 2020-2031
Figure 10.1:    Abbott Laboratories: Overall Financials, $Million, 2018-2020
Figure 10.2:    Abbott Laboratories: Net Revenue (by Segment) (Medical Devices), $Million, 2018-2020
Figure 10.3:    Abbott Laboratories: Net Revenue (by Region) (Medical Devices), $Million, 2018-2020
Figure 10.4:    Biotricity, Inc.: Overall Financials, $Million, 2018-2020
Figure 10.5:    Boston Scientific Corporation: Overall Financials, $Million, 2018-2020
Figure 10.6:    Boston Scientific Corporation: Net Revenue (by Segment), $Million, 2018-2020
Figure 10.7:    Boston Scientific Corporation: Net Revenue (by Region), $Million, 2018-2020
Figure 10.8:    CardioComm Solutions, Inc.: Overall Financials, $Million, 2018-2020
Figure 10.9:    CardioComm Solutions, Inc.: Net Revenue (by Segment), $Million, 2020
Figure 10.10:    CardioComm Solutions, Inc.: Net Revenue (by Region), $Million, 2018-2020
Figure 10.11:    Fukuda Denshi Co., Ltd.: Overall Financials, $Million, 2019-2021
Figure 10.12:    Fukuda Denshi Co., Ltd.: Net Revenue (by Segment), $Million, 2019-2021
Figure 10.13:    General Electric Company: Overall Financials, $Million, 2018-2020
Figure 10.14:    General Electric Company: Net Revenue (by Segment) (Healthcare), $Million, 2018-2020
Figure 10.15:    General Electric Company: Net Revenue (by Region), $Million, 2018-2020
Figure 10.16:    Hill-Rom Holdings, Inc.: Overall Financials, $Million, 2018-2020
Figure 10.17:    Hill-Rom Holdings, Inc.: Net Revenue (by Segment), $Million, 2018-2020
Figure 10.18:    Hill-Rom Holdings, Inc.: Net Revenue (by Region), $Million, 2018-2020
Figure 10.19:    iRhythm Technologies, Inc.: Overall Financials, $Million, 2018-2020
Figure 10.20:    Koninklijke Philips N.V.: Overall Financials, $Million, 2018-2020
Figure 10.21:    Koninklijke Philips N.V.: Net Revenue (by Segment), $Million, 2018-2020
Figure 10.22:    Koninklijke Philips N.V.: Net Revenue (by Region), $Million, 2018-2020
Figure 10.23:    Medtronic plc: Overall Financials, $Million, 2019-2021
Figure 10.24:    Medtronic plc: Net Revenue (by Segment) (Cardiovascular), $Million,  2019-2021
Figure 10.25:    Medtronic plc: Net Revenue (by Region), $Million, 2019-2021
Figure 10.26:    Nihon Kohden Corporation: Overall Financials, $Million, 2019-2021
Figure 10.27:    Nihon Kohden Corporation: Net Revenue (by Segment), $Million, 2019-2021
Figure 10.28:    Nihon Kohden Corporation: Net Revenue (by Region), $Million, 2019-2021
Figure 10.29:    OSI Systems, Inc.: Overall Financials, $Million, 2018-2020
Figure 10.30:    OSI Systems, Inc.: Net Revenue (by Segment), $Million, 2018-2020
Figure 10.31:    OSI Systems, Inc.: Net Revenue (by Region), $Million, 2018-2020
Figure 10.32:    Asahi Kasei Corporation: Overall Financials, $Million, 2019-2021
Figure 10.33:    Asahi Kasei Corporation: Net Revenue (by Segment), $Million, 2019-2021
Figure 10.34:    Asahi Kasei Corporation: Net Revenue (by Region), $Million, 2019-2021

FAQ's

Q. What is the estimated growth rate of global electrocardiographs market in the coming years?

The electrocardiographs is expected to grow witnessing a CAGR of 7.8% during the forecast period from 2021 to 2031.

Q. What are the possible market trends that can influence the growth of the global electrocardiographs market?

Trends that can influence the growth of the market include rise in demand for Holter monitors and development of insertable cardiac monitors.

Q. What are factors driving the growth of global electrocardiographs market?

The factors driving the growth of the market include growing demands for point-of-care diagnostic systems and rising end-user preference for non-invasive diagnostic technologies over invasive technologies

Q. What are end-users of the global electrocardiographs market?

Hospitals and clinics, home care settings and ambulatory surgical systems and others are end-users of the electrocardiographs.

Q. Which are the top market players operating in the global electrocardiographs market?

Abbott Laboratories, Biotricity, Inc., BIOTRONIK SE & Co. KG, Boston Scientific Corporation, CardioComm Solutions, Inc., Cardioline SpA, and Fukuda Denshi Co., Ltd., among others.

You may also like

Published Year: 2021

Global Radiation Therapy in the Oncology Market: Focus on Radiation Therapy Systems, Product Regulat

The radiation therapy in oncology report highlights that the market was valued at $5,481.8...

 
Published Year: 2021

Global Next Generation Ultrasound Systems Market: Focus on Product Type, Technology, and Application

The global next-generation ultrasound systems market was valued at $8,246.8 million in 2020...

 
Published Year: 2020

Global Point-of-Care Imaging Devices Market: Focus on Product Type, Technology Type, Clinical Utilit

The Global Point-of-Care Imaging Devices Market was valued to be $8.66 billion in 2019 and is...

 
Published Year: 2020

Global Tissue Imaging Market: Focus on Technology, Product, Application, End User, 14 Countries’ D

The global tissue imaging market was valued to be $14.42 billion in 2019 and is anticipated to...

 

Global Electrocardiographs Market

Focus on Product Type, End User, Region, COVID-19 Impact, Competitive Landscape, and 22 Countries Data - Analysis and Forecast, 2021-2031